[1] Ananthakrishnan AN. Clostridium difficile infection:epidemiology,risk factors and management[J]. Nat Vev gastro hepat,2011,1(8):17-26.
[2] 林瑞莲,彭明健,张茶英. 甲硝唑联合克林霉素治疗细菌性阴道病的效果研究[J]. 中外医学研究,2017,15(26):119-120.
[3] Leeds J A,Sachdeva M,Mullin S,et al. In vitro selection,via serial passage,of clostridium difficile mutants with reduced susceptibility to fidaxomicin or vancomycin[J]. J Antimicrob Chemother,2014,69(1):41-44.
|